Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression

BACKGROUND: Myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) are characterised by abnormal epigenetic repression and differentiation of bone marrow haematopoietic stem cells (HSCs). Drugs that reverse epigenetic repression, such as 5-azacytidine (5-AZA), induce haematological improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazachenka, Anastasiya, Young, George R., Attig, Jan, Kordella, Chrysoula, Lamprianidou, Eleftheria, Zoulia, Emmanuela, Vrachiolias, George, Papoutselis, Menelaos, Bernard, Elsa, Papaemmanuil, Elli, Kotsianidis, Ioannis, Kassiotis, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929315/
https://www.ncbi.nlm.nih.gov/pubmed/31870430
http://dx.doi.org/10.1186/s13073-019-0707-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929315/
https://www.ncbi.nlm.nih.gov/pubmed/31870430
http://dx.doi.org/10.1186/s13073-019-0707-x

Ejemplares similares